Abstract
At first sight it may seem an impossible task to cover the biochemical and cellular aspects of a variety of chronic destructive lung diseases encompassed by a term as broad as COPD. Indeed even if one assumes that the term is largely synonymous with emphysema, as suggested by Thurlbeck [1], it is clear that even this covers a variety of pathologically and anatomically distinct conditions. Whereas it is far from the scope of this chapter to argue the pros and cons of pathophysiologic similarities, it may well be that the basic processes that lead to COPD (whatever its pathologic features) have a common theme.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thurlbeck, W.M. (1976) Chronic Airflow Obstruction in Lung Disease. Saunders, Philadelphia.
Fletcher, C. and Peto, R. (1977) The natural history of chronic airflow obstruction, Br. Med. J., 1, 1645–8.
Jones, J.G., Minty, B.D., Lawler, P. et al. (1980) Increased alveolar epithelial permeability in cigarette smokers. Lancet, 1, 66–8.
Laurell, C-B. and Eriksson, S. (1963) The electrophoretical alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest., 15, 132–40.
Gross, P., Pfitzer, E.A., Tolker, E. et al. (1964) Experimental emphysema. Its production with papain in normal and silicotic rats. Arch. Environ. Health, 11, 50–8.
Eriksson S. (1964) Pulmonary emphysema and alpha1-antitrypsin deficiency. Acta Med. Scand., 175, 197–205.
Janoff A. and Scherer J. (1968) Mediators of inflammation in leukocyte lysosomes. IX Elastinolytic activity in granules of human polymorphonuclear leukocytes. J. Exp. Med., 128, 1137–51.
Turino, G.M., Senior, R.M., Garg, B.B. et al. (1969) Serum elastase inhibitor deficiency and alpha-1-antitrypsin deficiency in patients with obstructive emphysema. Science, 165, 709–11.
Ohlsson, K. (1971) Neutral leukocyte proteases and elastase inhibited by plasma alpha1-antitrypsin. Scand. J. Clin. Lab. Invest., 28, 251–3.
Lieberman, J. (1972) Digestion of antitrypsin deficient lung by leukoproteases. In: Pulmonary Emphysema and Proteolysis, (ed. C. Mittman), Academic Press, London, pp. 189–203.
Janoff, A., Sloan, B., Weinbaum, G. et al. (1977) Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev. Respir. Dis., 115, 461–78.
Kuhn, C., Slodkowska, J., Smith, T. and Starcher, B. (1980) The tissue response to exogenous elastase. Bull. Europ. Physiopath. Resp., 16 (suppl.), 127–37.
Witteis, E.H., Coalson, J.J., Welch, M.H. and Guenter, C.A. (1974) Pulmonary intravascular leukocyte sequestration: a potential mechanism of lung injury. Am. Rev. Respir. Dis., 109, 502–9.
Guenter, C.A., Coalson, J.J. and Jacques, J. (1981) Emphysema associated with intravascular leukocyte sequestration: comparison with papain-induced emphysema. Am. Rev. Respir. Dis., 123, 79–84.
Blackwood, R.A., Moret, J., Mandl, I. and Turino, G.M. (1984) Emphysema induced by intravenously administered endotoxin in an alpha1-antitrypsin-deficient rat model. Am. Rev. Respir. Dis., 130, 231–6.
Schwarzenberg, S.J., Sharp, H.L., Manthei, R.D. and Seelig, S. (1986) Hepatic α1-antitrypsin mRNA content in cirrhosis with normal and abnormal protease inhibitor phenotypes. Hepatology, 6, 1252–8.
Johannson, B.G., Kindmark, C-O., Trell, E.Y. and Wallheim, F.A. (1972) Sequential changes of plasma proteins after myocardial infarction. Scand. J. Clin. Lab. Invest., 29(suppl. 124); 117–26.
Stockley, R.A., Mistry, M., Bradwell, A.R. and Burnett, D. (1979) A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax, 34, 777–82.
Stockley, R.A. (1984) The measurement of soluble proteins in lung secretions. Thorax, 39, 241–7.
Stockley, R.A. and Burnett, D. (1979) Alpha1-antitrypsin and leukocyte elastase in infected and non-infected sputum. Am. Rev. Respir. Dis., 120, 1081–6.
Rabin, M., Watson, M., Kidd, V. et al. (1986) Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14. Som. Cell Mol. Genet., 12, 209–14.
Perlino, E., Cortese, R. and Ciliberto, G. (1987) The human alpha-1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. EMBO J., 6, 2767–72.
Eriksson, S. (1965) Studies in alpha1-antitrypsin deficiency. Acta Med. Scand., 177, (suppl. 432).
Mornex, J-F., Chytil-Weir, A., Martinet, Y. et al. (1986) Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin deficient individuals. J. Clin. Invest., 77, 1952–61.
Verbanac, K.M. and Heath, E.C. (1986) Biosynthesis processing and secretion of M and Z variant human α1-antitrypsin. J. Biol. Chem., 261, 9979–89.
Foreman, R.C., Judah, J.D. and Colman, A. (1984) Xenopus oocytes synthesise but do not secrete the Z variant of human α1-antitrypsin. FEBS Lett., 168, 84–8.
Nukiwa, T., Satoh, K., Brantly, M.L. et al. (1986) Identification of a second mutation in the protein coding sequence of the Z-type alpha-1-antitrypsin gene. J. Biol. Chem., 261, 15989–94.
Brantly, M.L., Courtney, M. and Crystal, R.G. (1988) Repair of the secretion defect in the Z form of α1-antitrypsin by addition of a second mutation. Science, 242, 1700–2.
Sifers, R.N., Hardick, C.P. and Woo, S.L.C. (1989) Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ α1-antitrypsin variant. J. Biol. Chem., 264, 2997–3001.
Lomas, D.A., Evans, D.Ll., Finch, J.T. and Carrell, R.W. (1992) The mechanism of Z α1-antitrypsin accumulation in the liver. Nature, 357, 605–7.
Curiel, D.T., Holmes, M.D., Okayama, H. et al. (1989) Molecular basis of the lung and liver disease associated with the α1-antitrypsin deficiency allele Mmalton. J. Biol. Chem., 264, 13938–45.
Seyama, K., Nukiwa, T., Takake K. et al. (1991) Siiyama (serine 53 [TCC] to phenylalanine 53 [TTC]). J. Biol. Chem., 266, 12627–32.
Crystal, R.G. (1989) The α1-antitrypsin gene and its deficiency states. Trends Genet., 5, 411–7.
Takahashi, H. and Crystal, R.G. (1990) Nullisola de procida: a novel sub-class of α1-antitrypsin deficiency alleles caused by a deletion of all α1-antitrypsin coding exons. Am. J. Hum. Genet., 47, 403–13.
Satoh, K., Nukiwa, T., Brantly, M. et al. (1988) Emphysema associated with complete absence of α1-antitrypsin in serum and the homozygous inheritance of a stop codon in an α1-antitrypsin-coding exon. Am. J. Hum. Genet., 42, 77–83.
Holmes, M., Curiel, D., Brantly, M. and Crystal, R.G. (1989) Characterization of the intracellular mechanism causing alpha-1-antitrypsin NullGranite Falls deficiency state. Am. Rev. Respir. Dis., 140, 1662–7.
Curiel, D.T., Chytil, A., Courtney, M. and Crystal, R.G. (1989) Serum α1-antitrypsin deficiency associated with the common S-type (Glu264-Val) mutation results from exaggerated pre-glycosylation intracellular degradation of α1-antitrypsin prior to secretion. J. Biol. Chem., 264, 10477–85.
Holmes, M.D., Brantly, M.L. and Crystal, R.G. (1990) Molecular analysis of the heterogeneity among the P-family of alpha-1-antitrypsin alleles. Am. Rev. Respir. Dis., 142, 1185–92.
Curiel, D.T., Stier, L.E. and Crystal, R.G. (1990) Molecular basis of α1-antitrypsin deficiency and emphysema associated with the α1-antitrypsin Mmineral springs allele. Mol. Cell Biol., 10, 47–56.
Cook, P.J.L. (1974) Genetic aspects of the Pi system. Postgrad. Med. J., 50, 362–4.
Larsson, C., Dirksen, H., Sundstrom, G. and Eriksson, S. (1976) Lung function studies in asymptomatic individuals with moderately (PiSZ) and severely (PiZ) reduced levels of α1-antitrypsin. Scand. J. Respir. Dis., 57, 267–80.
Tobin, M.J., Cook, P.J.L. and Hutchison, D.C.S. (1983) Alpha1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br. J. Dis. Chest, 77, 14–27.
Cox, D.W. and Levison, H. (1988) Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes). Am. Rev. Respir. Dis., 137, 371–5.
Morse, J.O., Lebowitz, M.D., Knudson, R.J. and Burrows, B. (1977) Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N. Engl. J. Med., 296, 1190–4.
Lieberman, J., Winter, B. and Sastre, A. (1986) Alpha-1-antitrypsin Pi types in 965 COPD patients. Chest, 89, 370–3.
Stockley R.A., (1979) Alpha1-antitryspin phenotypes in cor pulmonale due to chronic obstructive airways disease. Q. J. Med., 191, 419–28.
Morrison, H.M., Kramps, J.A., Burnett, D. and Stockley, R.A. (1987) Lung lavage fluid from patients with alpha-1-proteinase inhibitor deficiency or chronic obstructive bronchitis: antielastase function and cell profile. Clin. Sci., 72, 373–81.
Morrison, H.M., Kramps, J.A., Afford, S.C. et al. (1987) Elastase inhibitors in sputum from bronchitis patients with and without alpha1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase. Clin. Sci., 73, 19–28.
Gadek, J.E., Fells, G.A., Zimmerman, R.L. et al. (1981) Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J. Clin. Invest., 68, 889–98.
Wewers, M.D., Casolaro, M.A. and Crystal, R.G. (1987) Comparison of alpha1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha1-antitrypsin phenotype null-null before and during alpha1-antitrypsin augmentation therapy. Am. Rev. Respir. Dis., 135, 539–43.
Hubbard, R.C., Fells, G., Gadek, J. et al. (1991) Neutrophil accumulation in the lung in alpha-1-antitrypsin deficiency: spontaneous release of leukotriene B4 by alveolar macrophages. J. Clin. Invest., 88, 891–7.
Larsson, C (1978) Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, PiZ. Acta Med. Scand., 204, 345–51.
Reynolds, H.Y. and Newball, H.H. (1974) Analysis of proteins and respiratory cells from human lungs by bronchial lavage. J. Lab. Clin. Med., 84, 559–73.
Janus, E.D., Phillips, N.T. and Carrell, R.W. (1985) Smoking, lung function and alpha-1-antitrypsin deficiency. Lancet, 1, 152–4.
Cohen, B.H., Ball, W.C., Bias, W.B. et al. (1975) A genetic-epidemiologic study of chronic obstructive pulmonary disease. Johns Hopkins Med. J., 137, 95–104.
Cohen, B.H., Diamond, E.L., Graves, C.G. et al. (1977) A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet, ii, 523–6.
Silverman, E.K., Miletich, J.P., Pierce, J.A. et al. (1989) Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis., 140, 961–6.
Sveger, T. (1976) Liver disease in alpha-1-antitrypsin deficiency detected by screening of 200,000 infants. N. Engl. J. Med., 294, 1316–21.
Fagerhol, M.K. (1972) The incidence of alpha1-antitrypsin variants in chronic obstructive pulmonary disease. In: Pulmonary Emphysema and Proteolysis. (ed. C. Mittman), Academic Press, New York, pp. 51–4.
Jones, M.C. and Thomas, G.O. (1971) Alpha1 antitrypsin deficiency and pulmonary emphysema. Thorax, 26, 652–62.
Cox, D.W. and Mansfield, T. (1987) Prenatal diagnosis of α1 antitrypsin deficiency and estimates of fetal risk for disease. J. Med. Genet., 24, 52–9.
Sveger, T. (1984) Prospective study of children with α1-antitrypsin deficiency: eight-year-old follow up. J. Paediatr, 104, 91–4.
McNeil, T.F., Thelin, T., Aspegren-Jansson, E. and Sveger, T. (1986) Identifying children at high somatic risk: possible long-term effects on the parent’s attitudes and feelings associated with the child. Acta Psychiatr. Scand., 74, 341–6.
Sharp, H.L., Bridges, R.A., Krivit, W. and Freier, E.F. (1969) Cirrhosis associated with alpha1-antitrypsin deficiency: a previously unrecognised inherited disorder. J. Lab. Clin. Med., 73, 934–9.
Eriksson, S., Carlson, J. and Velvez, R. (1986) Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. N. Engl. J. Med., 314, 736–9.
Psacharopoulos, H.T., Mowat, A.P., Cook, P.J.L. et al. (1983) Outcome of liver disease associated with α1 antitrypsin deficiency (PiZ). Arch. Dis. Child., 58, 882–7.
Perlmutter, D.H., May, L.T. and Sehgal, P.B. (1989) Interferon β2/interleukin 6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J. Clin. Invest., 84, 138–44.
Gadek, J.E., Fulmer, J.D., Gelfand, J.A. et al. (1980) Danazol-induced augmentation of serum α1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J. Clin. Invest., 66, 82–7.
Wewers, M.D., Brantly, M.L., Casolaro, M.A. and Crystal, R.G. (1987) Evaluation of tamoxifen as a therapy to augment alpha-1-antitrypsin concentrations in Z homozygous alpha-1-antitrypsin deficient subjects. Am. Rev. Respir. Dis., 135, 401–2.
Eriksson, S. (1983) The effect of tamoxifen in the intermediate alpha1-antitrypsin deficiency associated with the phenotype PiSZ. Ann. Clin. Res., 15, 95–8.
Gadek, J.E., Klein, H., Holland, P.V. and Crystal, R.G. (1981) Replacement therapy of alpha1-antitrypsin deficiency: reversal of protease-anti-protease imbalance within the alveolar structures of PiZZ subjects. J. Clin. Invest., 68, 1158–65.
Wewers, M.D., Casolaro, M.A., Sellers, S.E. et al. (1987) Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med., 316, 1055–62.
Hubbard, R., Sellers, S., Czerski, D. et al. (1988) Biochemical efficacy and safety of monthly augmentation therapy for α1-antitrypsin deficiency. JAMA, 260, 1259–64.
Rosenberg, S., Barr, P.J., Najarian, R.C. and Hallewell, R.A. (1984) Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsin. Nature, 312, 77–80.
Casolaro, M.A., Fells, G., Wewers, M. et al. (1987) Augmentation of lung anti neutrophil elastase capacity with recombinant human α-1-antitrypsin. J. Appl. Physiol., 63, 2015–23.
Hubbard, R.C., McElvaney, N.G., Sellers, S.E. et al. (1989) Recombinant DNA-produced α1-antitrypsin administered by aerosol augments lower respiratory tract anti neutrophil elastase defenses in individuals with α1-antitrypsin deficiency. J. Clin. Invest., 84, 1349–54.
Wewers, M.D., Casolaro, M.A. and Crystal, R.G. (1987) Comparison of alpha-1-antitrypsin levels and anti neutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype Null-Null before and during alpha-1-antitrypsin augmentation therapy. Am. Rev. Respir. Dis., 135, 539–43.
Garver, R.I., Chytil, A., Courtney, M. and Crystal, R.G. (1987) Clonal gene therapy: transplanted mouse fibroblast clones express human alpha-1-antitrypsin gene in vivo. Science, 237, 762–4.
Rosenfeld, M.A., Siegfried, W., Yoshimura, K. et al. (1991) Adenovirus mediated transfer of a recombinant α1 antitrypsin gene to the lung epithelium in vivo. Science, 252, 431–4.
van Furth, R., Kramps, J.A., van der Putten, A.B.M.M. et al. (1968) Change in α1-antitrypsin phenotype after orthotopic liver transplant. Clin. Exp. Immunol., 66, 669–72.
Kimbel, P. and Weinbaum, G. (1975) Role of leucoproteases in the genesis of emphysema. In: Lung Metabolism, A.F Junod and R. de Haller (eds), Academic Press, New York, pp. 25–41.
Johnson, D. and Travis, J. (1979) The oxidative inactivation of human α1-proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem., 254, 4022–6.
Johnson, D. and Travis, J. (1977) Inactivation of human α1-proteinase inhibitor by thiol proteinases. Biochem. J., 163, 639–41.
Travis, J., Baugh, R., Giles, P.J. et al. (1978) Human leukocyte elastase and cathepsin G: isolation, characterization and interaction with plasma proteinase inhibitors. In: Neutral Proteinases of Human Polymorphonuclear Leukocytes. (eds. K. Havemann and A. Janoff), Urban and Schwarzenberg, Baltimore, pp. 118–28.
Carell, R.W., Evans, D. Ll. and P. E. Stein (1991) Mobile reactive centre of serpins and the control of thrombosis. Nature, 353, 576–8.
Gadek, J., Fells, G.A. and Crystal R.G. (1979) Cigarette smoking induces functional anti-protease deficiency in the lower respiratory tract of humans. Science, 206, 1315–6.
Carp, H. and Janoff, A. (1978) Possible mechanisms of emphysema in smokers: in vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by anti-oxidants. Am. Rev. Respir. Dis., 118, 617–21.
Janoff, A., Carp, H., Lee, D.K. and Drew, R.T. (1979) Cigarette smoke inhalation decreases alpha-1-antitrypsin activity in rat lung. Science, 206, 1313–4.
Carp, H., Miller, F., Hoidal, J.R. and Janoff, A. (1982) Potential mechanisms of emphysema: α1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidised methionine and has decreased elastase inhibitory capacity. Proc. Natl Acad. Sci., 79, 2041–5.
Hubbard, R.C., Ogushi, F., Fells, G.A. et al. (1987) Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of α1-antitrypsin rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest., 80, 1289–95.
Janoff, A., Carp, H., Laurent, P. and Raju, L. (1983) The role of oxidative processes in emphysema. Am. Rev. Respir. Dis., 127, S31–S38.
Abboud, R.T., Fera, T., Richter, A. et al. (1985) Acute effect of smoking on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis., 131, 79–85.
Stone, P., Calore, J.D., McGowan, S.E. et al. (1983) Functional alpha-1-protease inhibitor in the lower respiratory tract of smokers is not decreased. Science, 221, 1187–9.
Boudier, C., Pelletier, A., Pauli, G. and Bieth, J.G. (1983) The functional activity of alpha1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non smokers. Clin. Chim. Acta, 132, 309–15.
Gadek, J.E., Hunninghake, G.W., Fells, G.A. et al. (1980) Evaluation of the protease-antiprotease theory of human destructive lung disease. Bull. Europ. Physiopath. Resp., 16 (suppl.), 27–40.
Afford, S.C., Burnett, D., Campbell, E.J. et al. (1988) The assessment of α1-proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Biol. Chem. Hoppe Seyler, 369, 1065–74.
Afford, S.C., Stockley, R.A., Kramps, J.A. et al. (1985) Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. Anal. Biochem., 151, 125–30.
Campbell, E.J., Endicott, S.K. and Rios-Mollineda, R.A. (1987) Assessment of oxidation of alpha1-proteinase inhibitor in bronchoalveolar lining fluid by monoclonal immunoassay. Comparison of smokers and non smokers. Am. Rev. Respir. Dis., 135, no. 4, part 2: A156.
Abrams, W.R., Weinbaum, G., Weissbach, L. et al. (1981) Enzymatic reduction of oxidised α-1-proteinase inhibitor restores biological activity. Proc. Natl Acad. Sci., 78, 7483–6.
Stockley, R.A. and Afford, S.C. (1984) Qualitative studies of lung lavage alpha1-proteinase inhibitor. Hoppe-Seyler’s Z. Physiol. Chem., 365, 503–10.
Ogushi, F., Hubbard, R.C., Vogelmeier, C. et al. (1991) Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung α1-antitrypsin for neutrophil elastase. J. Clin. Invest., 87, 1060–5.
Llewellyn-Jones, C., Lomas, D., Carrell, R.W. and Stockley, R.A. (1993) The effect of M and Z variants of α1-antitrypsin on connective tissue degradation. Thorax, 48, 423.
Kalsheker, N.A., Hodgson, I., Watkins, G.L. et al. (1987) Deoxyribonucleic acid (DNA) polymorphism of the alpha1-antitrypsin (AAT) gene in chronic lung disease. Br. Med. J., 294, 1511–4.
Stockley, R.A. and Burnett, D. (1992) Proteinases and proteinase inhibitors in the pathogenesis of pulmonary emphysema in humans. In: Biochemistry of Pulmonary Emphysema. (eds C. Grassi, J. Travis, L. Casali and M. Luisetti) Springer Verlag, London, pp. 47–69.
Morgan, K., Scobie, G. and Kalsheker, N. (1992) The characterization of a mutation of the 3′ flanking sequence of the α1 antitrypsin gene commonly associated with chronic obstructive airways disease. Eur. J. Clin. Invest., 22, 134–7.
Totti, N., McCusker, R.T., Campbell, E.J. et al. (1984) Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science, 223, 169–71.
Kew, R.R., Ghebrehiwet, B. and Janoff, A. (1986) The role of complement in cigarette smoke-induced chemotactic activity of lung fluids. Am. Rev. Respir. Dis., 133, 478–81.
Merrill, W.W., Naegel, G.P., Matthay, R. A. and Reynolds, H.Y. (1980) Alveolar macrophage-derived chemotactic factor. Kinetics of in vitro production and partial characterization. J. Clin. Invest., 65, 268–76.
Nakamura, H., Yoshimura, K., McElvaney, N.G and Crystal, R.G. (1992) Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest., 89, 1478–84.
Ward, P.A. and Talamo, R.C. (1973) Deficiency of the chemotactic factor inactivators in human serum with alpha-1-antitrypsin deficiency. J. Clin. Invest., 52, 512–9.
Anderson, R., Theron, A.J., Richards, G.A. et al. (1991) Passive smoking by humans sensitizes circulating neutrophils. Am. Rev. Respir. Dis., 144, 570–4.
Taylor, J.C. and Kueppers, F. (1977) Electrophoretic mobility of leukocyte elastase of normal subjects and patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 116, 531–6.
Rodriguez, J.R., Seals, J.E., Radin, A. et al. (1979) Neutrophil lysozomal elastase activity in normal subjects and patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 119, 409–17.
Kramps, J.A., Bakker, W. and Dijkman, J.H. (1980) A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha-1-antitrypsin deficiency. Am. Rev. Respir. Dis., 121, 253–61.
Takahashi, H., Nukiwa, T., Basset, P. and Crystal, R.G. (1988) Myelomonocytic cell lineage expression of the neutrophil elastase gene. J. Biol. Chem., 263, 2543–7.
Burnett, D., Chamba, A., Hill, S.L. and Stockley, R.A. (1987) Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet, ii, 1043–6.
Hubbard, R., McElvaney, N. and Crystal, R.G. (1990) Amount of neutrophil elastase carried by neutrophils may modulate the extent of emphysema in α1-antitrypsin deficiency. Am. Rev. Respir. Dis., 141, A682.
Chamba, A., Afford, S.C. Stockley, R.A. and Burnett, D. (1991) Extracellular proteolysis of fibronectin by neutrophils: characterization and the effects of recombinant cytokines. Am. J. Respir. Cell Mol. Biol., 4, 330–7.
Campbell, E.J., Senior, R.M., McDonald, J.A. and Cox, D.W. (1982) Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J. Clin. Invest., 70, 845–52.
Damiano, V.V., Tsang, A., Kucich, U. et al. (1986) Immunolocalization of elastase in human emphysematous lungs. J. Clin. Invest., 78, 482–93.
Yi-Min, G., Yuan-jeu, Z., Wei-ci, L. et al. (1990) Damaging role of neutrophil elastase in the elastic fiber basement membrane in human emphysematous lung. Chin. Med. J., 103, 588–94.
Fox, B., Bull, T.B., Guz, A. et al. (1988) Is neutrophil elastase associated with elastic tissue in emphysema? J. Clin. Pathol., 41, 435–40.
Morrison, H.M., Welgus, H.G., Stockley, R.A. et al. (1990) Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. Am. J. Respir. Cell Mol. Biol., 2, 263–9.
MacNee, W., Wiggs, B., Beizberg, A.S. and Hogg, J.C. (1989) The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med., 321, 924–8.
Drost, E.M., Selby, C., Lannan, S. et al. (1992) Changes in neutrophil deformability following in vitro smoke exposure mechanism and protection. Am. J. Respir. Cell Mol. Biol., 6, 287–95.
Selby, C., Drost, E., Lannan, S. et al. (1991) Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 143, 1359–64.
Meier, H.L., Heck, L.W., Schulman, E.S. et al. (1985) Purified human mast cells and basophils release human elastase and cathepsin G by an IgE-mediated mechanism. Int. Arch. Allergy Appl. Immunol., 77, 179–83.
Campbell, E.J., Silverman, E.K. and Campbell, M.A. (1989) Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli and heterogeneity in elastase-mediated proteolytic activity. J. Immunol., 143, 2961–8.
Reilly, C.F. and Travis, J. (1980) The degradation of human elastin by neutrophil proteinases. Biochim. Biophys. Acta, 621, 147–57.
Boudier, C., Holle, C. and Bieth, J.G. (1981) Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J. Biol. Chem., 256, 10256–8.
Senior, R.M. and Campbell, E.J. (1983) Neutral proteinases from human inflammatory cells. Clin. Lab. Med., 3, 645–66.
Goldstein, W. and Doring, G. (1986) Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis., 134, 49–56.
Kao, R.C., Wehner, N.G., Skubitz, K.M. et al. (1988) Proteinase 3 — a distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest., 82, 1963–73.
Mass, B., Ikeda, T., Meranze, D.R. et al. (1972) Induction of experimental emphysema. Cellular and species specificity. Am. Rev. Respir. Dis., 106, 384–91.
Green, M.R., Lin, J.S., Berman, L.B. et al. (1979) Elastolytic activity of alveolar macrophages in normal dogs and human subjects. J. Lab. Clin. Med., 94, 549–62.
Banda, M.J. and Werb, Z. (1981) Mouse macrophage elastase. Purification and characterization as a metallo proteinase. Biochem. J., 193, 589–605.
Campbell, E.J., White, R.R., Senior, R.M. et al. (1979) Receptor mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro. J. Clin. Invest., 64, 824–33.
Senior, R.M., Connolly, N.L., Cury, J.D. et al. (1989) Elastin degradation by human alveolar macrophages. Am. Rev. Respir. Dis., 139, 1251–6.
Albin, R.J., Senior, R.M., Welgus, H.G. et al. (1987) Human alveolar macrophages secrete an inhibitor of metallo-proteinase elastase. Am. Rev. Respir. Dis., 135, 1281–5.
Reilly, J.J., Mason, R.W., Chen, P. et al. (1989) Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. Biochem. J., 257, 493–8.
Silver, I.A., Murrills, R.J. and Etherington, D.J. (1988) Micro-electrode studies on the acid environment beneath adherent macrophages and osteoclasts. Exp. Cell Res., 175, 266–76.
Burnett, D., Crocker, J. and Stockley, R.A. (1983) Cathepsin B-like cysteine proteinase activity in sputum and immunohistologic identification of cathepsin B in alveolar macrophages. Am. Rev. Respir. Dis., 128, 915–9.
Lesser, M., Padilla, M.L. and Cardozo, C. (1992) Induction of emphysema in hamsters by intratracheal instillation of cathepsin B. Am. Rev. Respir. Dis., 145, 661–8.
Janoff, A., Raju, L. and Dearing, R. (1983) Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and non smokers. Am. Rev. Respir. Dis., 127, 540–4.
Niederman, M.S., Fritts, L.I., Merrill, W.W. et al. (1984) Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha-1-antiprotease. Am. Rev. Respir. Dis., 129, 943–7.
Fera, T., Abboud, R.T., Richter, A. and Johal, S.S. (1986) Acute effect of smoking on elastase-like esterase activity and immunologic neutrophil elastase levels in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis., 133, 568–73.
Smith, S.F., Guz, A., Cooke, N.T. et al. (1985) Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin. Sci., 69, 17–27.
McLeod, R., Mack, D.G., McLeod, E.G. et al. (1985) Alveolar macrophage function and inflammatory stimuli in smokers with and without obstructive lung disease. Am. Rev. Respir. Dis., 131, 377–84.
Burnett, D., Afford, S.C., Campbell, E.J. et al. (1988) Evidence for lipid-associated serine proteases and metalloproteases in human bronchoalveolar lavage fluid. Clin. Sci., 75, 601–7.
Burnett, D. and Stockley, R.A. (1985) Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroid and antibiotic treatment. Clin. Sci., 68, 469–74.
Buttle, D.J., Abrahamson, M., Burnett, D. et al. (1991) Human sputum cathepsin B degrades proteoglycan, is inhibited by α2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem. J., 276, 325–31.
Johnson, D.A., Barrett, A.J. and Mason, R.W. (1986) Cathepsin L inactivates α1-proteinase inhibitor by cleavage in the reactive site region. J. Biol. Chem., 261, 14748–51.
Banda, M.J., Clark, E.J. and Werb, Z. (1980) Limited proteolysis by macrophage elastase inactivates human α1 proteinase inhibitor. J. Exp. Med., 152, 1563–70.
Morihara, K., Tsuzuki, H. and Oda, K. (1979) Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma α1-proteinase inhibitor. Inf. Immun., 24, 188–93.
Boudier, C., Pelletier, A., Gast, A. et al. (1987) The elastase inhibitory capacity and the α1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects. Biol. Chem. Hoppe Seyler, 368, 981–90.
Morrison, H.M., Kramps, J.A., Afford, S.C. et al. (1987) The effect of assay conditions on the measurement of anti-elastase function in lung secretions. Clin. Chim. Acta, 162, 165–74.
Kramps, J.A., Morrison, H.M., Burnett, D. et al. (1987) Determination of elastase inhibitory activity of alpha1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates. Scand. J. Clin. Lab. Invest., 47, 405–10.
Vogelmeier, C., Hubbard, R.C., Fells, G.A. et al. (1991) Anti-neutrophil elastase defence of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Invest., 87, 482–8.
Sallenave, J-M., Marsden, M.D. and Ryle, A.P. (1992) Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Biol. Chem. Hoppe Seyler, 373, 27–33.
Mooren, H.W.D., Kramps, J.A., Franken, C. et al. (1983) Localisation of a low molecular weight bronchial protease inhibitor in the human peripheral lung. Thorax, 38, 180–3.
Kramps, J.A., Franken, C. and Dijkman, J. (1988) Quantity of anti leucoprotease relative to α1-proteinase inhibitor in peripheral air spaces of the human lung. Clin. Sci., 75, 351–3.
Stockley, R.A. and Morrison, H.M. (1990) Elastase inhibitors of the respiratory tract. Eur. Respir. J., 3(suppl. 9), 9–15.
Dupuit, F., Jacquot, J., Spilmont, C. et al. (1993) Vectorial delivery of newly-synthesised proteins by human tracheal gland cells in culture. Epith. Cell Biol., 2, 91–9.
Willems, L.N.A., Otto-Verberne, C.J.M., Kramps, J.A. et al. (1986) Detection of anti-leukoprotease in connective tissue of the lung. Histochemistry, 86, 165–8.
Rice, W.G. and Weiss, S.J. (1990) Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science, 249, 178–81.
Aronsen, K.F., Ekelund, G., Kindmark, C.O. and Laurell, C-B. (1972) Sequential changes of plasma proteins after surgical trauma. Scand. J. Clin. Lab. Invest., 29 (suppl.), 127–36.
Beatty, K., Bieth, J. and Travis, J. (1980) Kinetics of association of serine proteinases with native and oxidised alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem., 255, 3931–4.
Stockley, R.A. and Burnett, D. (1980) Alpha1-antichymotrypsin in infected and non-infected sputum. Am. Rev. Respir. Dis., 122, 81–8.
Berman, G., Afford, S.C., Burnett, D. and Stockley, R.A. (1986) α-1-antichymotrypsin in lung secretions is not an effective proteinase inhibitor. J. Biol. Chem., 261, 14094–9.
Burnett, D., McGillivray, D.H. and Stockley, R.A. (1984) Evidence that alveolar macrophages can synthesise and secrete alpha1-antichymotrypsin. Am. Rev. Respir. Dis., 125, 473–6.
Stockley, R.A., Shaw, J., Afford, S.C. et al. (1990) Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am. J. Respir. Cell Mol. Biol., 2, 163–70.
Burnett, D., Reynolds, J.J., Ward, R.V. et al. (1986) Tissue inhibitor of metalloproteinase (TIMP) and collagenase inhibitory activity in sputum from patients with chronic obstructive bronchitis: the effect of corticosteroid therapy. Thorax, 41, 740–5.
Stockley, R.A. (1987) Antielastases in lung lavage from patients with emphysema. In: Pulmonary Emphysema and Proteolysis 1986, (eds. J.C. Taylor and C. Mittman), Academic Press, Orlando, pp. 277–82.
White, R., Habicht, G.S., Godfrey, H.P. et al. (1981) Secretion of elastase and alpha-2-macroglobulin by cultured murine peritoneal macrophages: studies on their interaction. J. Lab. Clin. Med., 97, 718–28.
Burnett, D. and Stockley, R.A. (1981) Serum and sputum alpha2-macroglobulin in patients with chronic obstructive airways disease. Thorax, 36, 512–6.
Buttle, D.J., Burnett, D. and Abrahamson, M. (1990) Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. Scand. J. Clin. Lab. Invest., 50, 509–16.
Hochstrasser, K., Albrecht, G.J., Schonberger, O.L. et al. (1981) An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization. Hoppe Seylers Z. Physiol. Chem., 362, 1369–75.
Stockley, R.A. (1987) Bronchiectasis — new therapeutic approaches based on pathogenesis. In: Clinics in Chest Medicine. Saunders, Philadelphia, vol. 8, No. 3, pp. 481–94.
Stockley, R.A. (1988) Chronic bronchitis: the antiproteinase/proteinase balance and the effect of infection and corticosteroids. In: Clinics in Chest Medicine, Saunders, Philadelphia, vol. 9, pp. 643–56.
Lucey, E.C., Stone, P.J., Breuer, R. et al. (1985) Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters with in vitro observations on elastolysis by these enzymes. Am. Rev. Respir. Dis., 132, 362–6.
Sommerhoff, C.P., Nadel, J.A., Basbaum, C.B. and Caughey, G.H. (1990) Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J. Clin. Invest., 85, 682–9.
Amitani, R., Wilson, R., Rutman, A. et al. (1991) Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am. J. Respir. Cell Mol. Biol., 4, 26–32.
Smallman, L.A., Hill, S.L. and Stockley, R.A. (1984) Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax, 39, 663–7.
Stockley, R.A., Hill, S.L., Morrison, H.M. and Starkie, C.M. (1984) Elastinolytic activity in sputum and its relation to purulence and lung function in patients with bronchiectasis. Thorax, 39, 408–13.
Jackson, A.H., Hill, S.L., Afford, S.C. and Stockley, R.A. (1984) Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur. J. Respir. Dis., 65, 114–24.
Suter, S., Schaad, U.B., Roux, L. et al. (1984) Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis., J. Infect. Dis., 149, 523–31.
Stockley, R.A., Shaw, J., Hill, S.L. and Burnett, D. (1988) Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretions. Clin. Sci., 74, 645–50.
Solomon, A. (1978) Possible role of PMN proteinases in immunoglobulin degradation and amyloid formation. In: Neutral Proteinases of Human Polymorphonuclear Leukocytes (eds K. Havemann and A. Janoff), Urban & Schwarzenberg, Baltimore, pp. 423–38.
Berger, M., Sorensen, R.U., Tosi, M.F. et al. (1989) Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J. Clin. Invest., 84, 1302–13.
McElvaney, N.G., Hubbard, R.C., Birrer, P. et al. (1991) Aerosol α1-antitrypsin treatment for cystic fibrosis. Lancet, 337, 392–4.
Buhl, R., Vogelmeier, C., Critenden, M. et al. (1990) Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc. Natl Acad. Sci., 87, 4063–7.
Cantin, A., North, S.L., Hubbard, R.C. and Crystal, R.G. (1987) Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol., 63, 152–7.
Rudolphus, A., Kramps, J.A. and Dijkman, J.H. (1991) Inhibition of experimental emphysema by human antileukoprotease. Eur. Respir. J., 4, 31–9.
Janoff, A. and Dearing, R. (1980) Prevention of elastase-induced experimental emphysema by oral administration of a synthetic elastase inhibitor. Am. Rev. Respir. Dis., 121, 1025–9.
Stone, P.J., Lucey, E.C. and Snider, G.L. (1990) Induction and exacerbation of emphysema in hamsters with human neutrophil elastase inactivated reversibly by a peptide boronic acid. Am. Rev. Respir. Dis., 141, 47–52.
Chediak, M. (1952) Nouvelle anomalie leucocytaire de caractere constitutionnel et familial. Rev. Haematol., 7, 362–7.
Burnett, D., Crocker, J., Afford, S.C. et al. (1986) Cathepsin B synthesis by the HL60 promyelocytic cell line: effects of stimulating agents and anti-inflammatory compounds. Biochim. Biophys. Acta, 887, 283–90.
Lomas, D.A., Ip, M., Chamba, A. and Stockley, R.A. (1991) The effect of in vitro and in vivo dexamethasone on human neutrophil function. Agents Actions, 33, 279–85.
Wiggins, J., Elliot, J.A., Stevenson, R.D. and Stockley, R.A. (1982) Effect of corticosteroids on sputum sol phase protease inhibitors in chronic obstructive pulmonary disease. Thorax, 37, 652–6.
Morrison, H.M., Afford, S.C. and Stockley, R.A. (1984) Inhibitory capacity of alpha1-antitrypsin in lung secretions: variability and the effect of drugs. Thorax, 39, 510–6.
Burnett, D., Chamba, A., Hill, S.L. and Stockley, R.A. (1989) Effects of plasma, tumour necrosis factor, endotoxin and dexamethasone on extracellular proteolysis by neutrophils from healthy subjects and patients with emphysema. Clin. Sci., 77, 35–41.
Thompson, A.B., Mueller, M.B., Heires, A.J. et al. (1992) Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am. Rev. Respir. Dis., 146, 389–95.
Weir, D., Jones, S., Chamba, A. et al. (1990) The effect of inhaled beclomethasone diproprionate on peripheral neutrophil function in patients with chronic airflow obstruction. Thorax, 45, 323p.
Cohen, A.B., Girard, W., McLarty, J. et al. (1990) A controlled trial of colchicine to reduce the elastase load in the lungs of cigarette smokers with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 142, 63–72.
Ip, M., Lomas, D.A., Shaw, J. et al. (1990) Effect of non-steroidal anti-inflammatory drugs on neutrophil chemotaxis — an in vitro and in vivo study. Br. J. Rheumatol., 29, 363–7.
Lomas, D.A., Carrell, R.W. and Stockley, R.A. (1991) Inhibition of neutrophil chemotaxis by active mutants of α1-antitrypsin. Thorax, 46, 757p.
Weitz, J.I., Crowley, K.A., Landman, S.L. et al. (1987) Increased neutrophil elastase activity in cigarette smokers. Ann. Intern. Med., 107, 680–2.
Weitz, J.I., Landman, S.L., Crowley, K.A. et al. (1986) Development of an assay for in vivo human neutrophil elastase activity: increased elastase activity in patients with alpha-1-proteinase inhibitor deficiency. J. Clin. Invest., 78, 155–62.
Mumford, R.A., Williams, H., Mao, J. et al. (1991) Direct assay of Aα (1–21), a PMN elastase-specific cleavage product of fibrinogen in the chimpanzee. Ann. N.Y. Acad. Sci., 624, 167–78.
Weitz, J.I. (1991) Development and application of assays for elastase-specific fibrinogen fragments. Ann. N.Y. Acad. Sci., 624, 154–66.
Janoff, A., Chanana, A.D., Joel, D.D. et al. (1983) Evaluation of the urinary desmosine radioimmune assay as a monitor of lung injury after endobronchial elastase instillation in sheep. Am. Rev. Respir. Dis., 128, 545–51.
Kucich, U., Christner, P., Weinbaum, G. and Rosenbloom, J. (1980) Immunologic identification of elastin-derived peptides in the serums of dogs with experimental emphysema. Am. Rev. Respir. Dis., 122, 461–5.
Harel, S., Janoff, A., Yu, S.Y. et al. (1980) Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am. Rev. Respir. Dis., 122, 769–73.
Schriver, E.E., Davidson, J.M., Sutcliffe, M.C. et al. (1992) Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers and patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 145, 762–6.
Shapiro, S.D., Endicott, S.K., Province, M.A. et al. (1991) Marked longevity of human lung parenchymal elastic fibres deduced from prevalence of d-Aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest., 87, 1828–34.
Lane, R.E. and Campbell, A.C.P. (1954) Fatal emphysema in two men making a copper cadmium alloy. Br. J. Ind. Med., 11, 118–22.
Thurlbeck, W.M. and Foley, F.D. (1963) Experimental pulmonary emphysema: the effect of intratracheal injection of cadmium chloride solution in the guinea pig. Am. J. Pathol., 42, 431–41.
Niewoehner, D.E. and Hoidal, J.R. (1982) Lung fibrosis and emphysema: divergent responses to a common injury. Science, 217, 359–60.
Hoidal, J.R., Niewoehner, D.E., Rao, N.V. and Hibbs, M.S. (1985) The role of neutrophils in the development of cadmium-chloride-induced emphysema in lathyrogen-fed hamsters. Am. J. Pathol., 120, 22–9.
Leopold, J.G. and Gough, J. (1957) The centrilobular form of hypertrophie emphysema and its relation to chronic bronchitis. Thorax, 12, 219–35.
Lewis, G.P., Jusko, W.J., Coughlin, L.L. and Hartz, S. (1972) Contribution of cigarette smoking to cadmium accumulation in man. Lancet, i, 291–2.
Hirst, R.N., Perry, H.M., Cruz, M.G. and Pierce, J.A. (1973) Elevated cadmium concentrations in emphysematous lungs. Am. Rev. Respir. Dis., 108, 30–9.
Riley, D.J., Berg, R.A., Edelman, N.H. and Prockap, D.J. (1980) Prevention of collagen deposition following pulmonary oxygen toxicity in the rat by cis-4-hydroxy-1-proline. J. Clin. Invest., 65, 643–51.
Glasgow, J.E., Pietra, G.G., Abrams, W.R. et al. (1987) Neutrophil recruitment and degranulation during induction of emphysema in the rat by nitrogen dioxide. Am. Rev. Respir. Dis., 135, 1129–36.
Lam, C., Kattan, M., Collins, A. and Kleinerman, J. (1983) Long term sequelae of bronchiolitis induced by nitrogen dioxide in hamster. Am. Rev. Respir. Dis., 128, 1020–3.
Haydon, G.B., Davidson, J.T. and Lillington, G.A. (1967) Nitrogen dioxide-induced emphysema in rabbits. Am. Rev. Respir. Dis., 95, 797–805.
Hyde, D., Orthoeffer, J., Dungworth, D. et al. (1978) Morphometric and morphologic evaluation of pulmonary lesions in beagle dogs chronically exposed to high ambient levels of air pollutants. Lab. Invest., 38, 455–69.
Kleinerman, J. and Ip, M.P.C. (1979) Effect of nitrogen dioxide on elastin and collagen contents of the lung. Arch. Environ. Health, 34, 228–32.
Sahebjami, H. and Wirman, J.A. (1981) Emphysema-like changes in the lungs of starved rats. Am. Rev. Respir. Dis., 124, 619–24.
Wilson, D.O., Rogers, R.M. and Hoffman, R.M. (1985) Nutrition and chronic lung disease. Am. Rev. Respir. Dis., 132, 1347–65.
Cupo, L.N., Pyeritz, R.E., Olson, J.L. et al. (1981) Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema and cerebral heterotopias. Am. J. Med., 71, 1051–8.
Harris, R.B., Heaphy, M.R. and Perry, H.O. (1978) Generalised elastolysis (cutis laxa). Am. J. Med., 65, 815–22.
Olsen, D.R., Fazio, M.J., Shambon, A.T. et al. (1988) Cutis laxa: reduced elastin gene expression in skin fibroblast cultures as determined by hybridization with a homologous cDNA and an exon1-specific oligonucleotide. J. Biol. Chem., 263, 6465–7.
Byers, P.H., Narayanan, A.S., Bornstein, P. et al. (1976) An x-linked form of cutis laxa due to deficiency of lysyloxidase. Birth Defects, 12, 293–8.
Kuhn, C. and Starcher, B.C. (1980) The effect of lathyrogens on the evaluation of elastase-induced emphysema. Am. Rev. Respir. Dis., 122, 453–60.
O’Dell, B.L., Kilburn, K.H., McKenzie, W.N. and Thurston, R.J. (1978) The lung of the copper deficient rat. Am. J. Pathol., 91, 413–32.
Soskel, N.T., Watanabe, S., Hammond, E. et al. (1982) A copper deficient, zinc supplement diet produces emphysema in pigs. Am. Rev. Respir. Dis., 126, 316–25.
Green, M.C., Sweet, H.O. and Bunker, L.E. (1976) Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am. J. Pathol., 82, 493–512.
Martorana, P.A., van Even, P.E., Gardi, C. and Lungarella, G. (1989) A 16-month study of the development of genetic emphysema in tight-skin mice. Am. Rev. Respir. Dis., 139, 226–32.
Giovanni, A., Rossi, A., Hunninghake, G.W. et al. (1984) Hereditary emphysema in the tight-skin mouse. Am. Rev. Respir. Dis., 139, 850–5.
Gardi, C., Martorana, P.A., van Even, P. et al. (1990) Serum anti-elastase deficiency in tight-skin mice with genetic emphysema. Exp. Mol. Path., 52, 46–53.
Starcher, B. and James, H. (1991) Evidence that genetic emphysema in tight-skin mice is not caused by neutrophil elastase. Am. Rev. Respir. Dis., 143, 1365–8.
D’Armiento, J., Dalai, S.S., Okaela, Y. et al. (1992) Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell, 71, 955–61.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Stockley, R.A. (1995). Biochemical and Cellular Mechanisms. In: Calverley, P.M.A., Pride, N.B. (eds) Chronic Obstructive Pulmonary Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4525-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-4525-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-46450-8
Online ISBN: 978-1-4899-4525-9
eBook Packages: Springer Book Archive